Business Context and Reporting Period
Company: Achieve Life Sciences, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: November 14, 2022
Reporting Period: Third quarter ended September 30, 2022
Business Context: The filing serves as a notification that the company issued a press release announcing its financial results for the third quarter of 2022. The press release is included as Exhibit 99.1.
Key Financial Metrics
The provided text is a cover sheet for the Form 8-K and does not contain specific financial data. It references a press release (Exhibit 99.1) for details on revenue, profit, cash flow, margins, debt, and liquidity. Consequently, the filing text does not provide clear values for these metrics.
Material Changes
No material changes regarding financial performance or operations are detailed in the text of this specific filing. The document solely announces the availability of the third-quarter results.
Guidance, Outlook, and Risks
The text does not contain management commentary, forward-looking guidance, risk factors, or contingencies. These items are presumed to be contained within the referenced press release (Exhibit 99.1), which is not included in the input text.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated November 14, 2022) for actual Q3 2022 financial figures.
- Verify the company's cash position and burn rate, as this filing does not disclose liquidity details.
- Confirm any updates to the company's operational milestones or product pipeline mentioned in the full press release.
- Check for any subsequent filings that may incorporate the results by reference.